Vofatamab (Anti-FGFR3 / CD333)

Ask supplier a question | View on supplier's website

Vofatamab (Anti-FGFR3 / CD333) is a monoclonal antibody targeting FGFR3. Vofatamab blocks activation of both the wildtype and genetically activated receptor. Vofatamab can be used in the research of metastatic urothelial carcinoma (mUC). MW: 145.5 KD.

Supplier	Selleck Chemicals
Product #	A2495
Sku #	A2495-1mg*25
Pricing	1mg*25, $4170.00

Feedback